Br.C(O)(=O)C.[C:6]([NH:11][CH:12]1[CH2:20][C:19]2[C:14](=[CH:15][CH:16]=[C:17]([C:21]3[CH2:22][CH2:23][C:24](=[O:27])[NH:25][N:26]=3)[CH:18]=2)[CH2:13]1)(=[O:10])[CH2:7][CH2:8][CH3:9].CS(C)=O>C(O)(=O)C>[C:6]([NH:11][CH:12]1[CH2:20][C:19]2[C:14](=[CH:15][CH:16]=[C:17]([C:21]3[CH:22]=[CH:23][C:24](=[O:27])[NH:25][N:26]=3)[CH:18]=2)[CH2:13]1)(=[O:10])[CH2:7][CH2:8][CH3:9]20 m of a 25% hydrogen bromide-acetic acid solution was added to 4.00 g of 2-butyrylamino-5-[4,5-dihydropyridazin-3(2H)-on-6-yl]indane suspended in 45 ml of acetic acid, and then 1.14 ml of dimethyl sulfoxide was added to the mixture. The resulting mixture was stirred at room temperature for 3.5 hours. Hydrogen bromide-acetic acid was removed, and the residue was recrystallized from hydrous ethanol to obtain 3.50 g of 2-butyrylamino-5-[pyridazin-3(2H)-on-6-yl]indane.